---
title: "Abbott’s Esprit BTK system receives CE mark"
date: "2025-08-25T16:00:42.000Z"
publishedDate: "25 août 2025"
summary: "Abbott today announced it has received CE mark approval in Europe for the Esprit BTK everolimus-eluting resorbable scaffold system (Esprit BTK system), a technology designed for the treatment of below-the-knee (BTK) peripheral arterial disease (PAD). Abbott notes that the Esprit BTK system is the first resorbable scaffold of its kind for use below the knee."
importance: ""
sourceUrl: "https://interventionalnews.com/abbotts-esprit-btk-system-receives-ce-mark/"
tags: ["France", "Actualité", "Interventional News — Latest"]
permalink: "/papers/2025-08-25-abbotts-esprit-btk-system-receives-ce-mark"
imageUrl: "http://interventionalnews.com/wp-content/uploads/sites/13/2025/08/Abbott-logo-web.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://interventionalnews.com/abbotts-esprit-btk-system-receives-ce-mark/"
---

![Abbott’s Esprit BTK system receives CE mark](http://interventionalnews.com/wp-content/uploads/sites/13/2025/08/Abbott-logo-web.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://interventionalnews.com/abbotts-esprit-btk-system-receives-ce-mark/*

## L’essentiel

Abbott today announced it has received CE mark approval in Europe for the Esprit BTK everolimus-eluting resorbable scaffold system (Esprit BTK system), a technology designed for the treatment of below-the-knee (BTK) peripheral arterial disease (PAD). Abbott notes that the Esprit BTK system is the first resorbable scaffold of its kind for use below the knee.

## Lien source

https://interventionalnews.com/abbotts-esprit-btk-system-receives-ce-mark/
